By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Alexza Pharmaceuticals, Inc. 

2091 Stierlin Court

Mountain View  California  94043  U.S.A.
Phone: 650-944-7000 Fax: 650-944-7999



Company News
Alexza Pharma (ALXA) To Report 2016 First Quarter Financial Results And Provide Corporate Update On Wednesday, May 11, 2016 4/28/2016 6:38:10 AM
Bay Area's Alexza Pharma (ALXA) Reports Q4 Loss, Warns It May Shut Down 3/29/2016 7:55:10 AM
Alexza Pharma (ALXA) To Report 2015 Year End Financial Results And Provide Company Update On Monday, March 28, 2016 3/16/2016 6:30:06 AM
Alexza Pharma (ALXA) Receives Positive Nasdaq Listing Determination 3/10/2016 5:59:21 AM
Alexza Pharma (ALXA) Confirms Grupo Ferrer Non-Binding Letter Of Intent 3/1/2016 8:20:45 AM
Alexza Pharma (ALXA) Reacquires U.S. Commercial Rights For ADASUVE (loxapine) Inhalation Powder 2/24/2016 7:32:16 AM
Alexza Pharma (ALXA) Announces Receipt Of NASDAQ Staff Determination; Alexza To Request Hearing With NASDAQ Listing Qualifications Panel 12/23/2015 7:03:36 AM
Alexza Pharma (ALXA) Announces Interim Results From Its Phase 2a Study Of AZ-002 (Staccato alprazolam) In Epilepsy Patients 12/22/2015 7:41:28 AM
Alexza Pharma (ALXA) Reports 2015 Third Quarter Financial Results 11/6/2015 7:30:46 AM
Alexza Pharma (ALXA) and Teva (TEVA) Break Up Over Adasuve 11/2/2015 6:20:06 AM